Global Pediatric Influenza Treatment Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-16930949 | Publishing Date : 04-Dec-2020 | No. of pages : 119
Detailed TOC of Global Pediatric Influenza Treatment Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Pediatric Influenza Treatment1.1 Pediatric Influenza Treatment Market Overview
1.1.1 Pediatric Influenza Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Pediatric Influenza Treatment Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Pediatric Influenza Treatment Market Size by Region (2015-2026)
1.4 Global Pediatric Influenza Treatment Historic Market Size by Region (2015-2020)
1.5 Global Pediatric Influenza Treatment Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Pediatric Influenza Treatment Market Size YoY Growth (2015-2026)
1.6.1 North America Pediatric Influenza Treatment Market Size YoY Growth (2015-2026)
1.6.2 Europe Pediatric Influenza Treatment Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Pediatric Influenza Treatment Market Size YoY Growth (2015-2026)
1.6.4 Latin America Pediatric Influenza Treatment Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Pediatric Influenza Treatment Market Size YoY Growth (2015-2026)
2 Pediatric Influenza Treatment Market Overview by Type
2.1 Global Pediatric Influenza Treatment Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Pediatric Influenza Treatment Historic Market Size by Type (2015-2020)
2.3 Global Pediatric Influenza Treatment Forecasted Market Size by Type (2021-2026)
2.4 Antiviral Drug
2.5 Antipyretic
2.6 Neuraminidase inhibitor
2.7 Others
3 Pediatric Influenza Treatment Market Overview by Application
3.1 Global Pediatric Influenza Treatment Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Pediatric Influenza Treatment Historic Market Size by Application (2015-2020)
3.3 Global Pediatric Influenza Treatment Forecasted Market Size by Application (2021-2026)
3.4 Hospitals
3.5 Clinics
3.6 Ambulatory Surgical Centers
3.7 Others
4 Global Pediatric Influenza Treatment Competition Analysis by Players
4.1 Global Pediatric Influenza Treatment Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Influenza Treatment as of 2019)
4.3 Date of Key Manufacturers Enter into Pediatric Influenza Treatment Market
4.4 Global Top Players Pediatric Influenza Treatment Headquarters and Area Served
4.5 Key Players Pediatric Influenza Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Pediatric Influenza Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 F. Hoffmann-La Roche Ltd
5.1.1 F. Hoffmann-La Roche Ltd Profile
5.1.2 F. Hoffmann-La Roche Ltd Main Business
5.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Products, Services and Solutions
5.1.4 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.1.5 F. Hoffmann-La Roche Ltd Recent Developments
5.2 GlaxoSmithKline Plc.
5.2.1 GlaxoSmithKline Plc. Profile
5.2.2 GlaxoSmithKline Plc. Main Business
5.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Products, Services and Solutions
5.2.4 GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.2.5 GlaxoSmithKline Plc. Recent Developments
5.3 NATCO Pharma Limited.
5.5.1 NATCO Pharma Limited. Profile
5.3.2 NATCO Pharma Limited. Main Business
5.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Products, Services and Solutions
5.3.4 NATCO Pharma Limited. Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.3.5 NESHER PHARMS Recent Developments
5.4 NESHER PHARMS
5.4.1 NESHER PHARMS Profile
5.4.2 NESHER PHARMS Main Business
5.4.3 NESHER PHARMS Pediatric Influenza Treatment Products, Services and Solutions
5.4.4 NESHER PHARMS Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.4.5 NESHER PHARMS Recent Developments
5.5 Johnson & Johnsons Inc.
5.5.1 Johnson & Johnsons Inc. Profile
5.5.2 Johnson & Johnsons Inc. Main Business
5.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Products, Services and Solutions
5.5.4 Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.5.5 Johnson & Johnsons Inc. Recent Developments
5.6 Cipla
5.6.1 Cipla Profile
5.6.2 Cipla Main Business
5.6.3 Cipla Pediatric Influenza Treatment Products, Services and Solutions
5.6.4 Cipla Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.6.5 Cipla Recent Developments
5.7 Hetero Pharma
5.7.1 Hetero Pharma Profile
5.7.2 Hetero Pharma Main Business
5.7.3 Hetero Pharma Pediatric Influenza Treatment Products, Services and Solutions
5.7.4 Hetero Pharma Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.7.5 Hetero Pharma Recent Developments
5.8 Teva Pharmaceutical pvt. Ltd.
5.8.1 Teva Pharmaceutical pvt. Ltd. Profile
5.8.2 Teva Pharmaceutical pvt. Ltd. Main Business
5.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Products, Services and Solutions
5.8.4 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.8.5 Teva Pharmaceutical pvt. Ltd. Recent Developments
5.9 Olainfarm JSC
5.9.1 Olainfarm JSC Profile
5.9.2 Olainfarm JSC Main Business
5.9.3 Olainfarm JSC Pediatric Influenza Treatment Products, Services and Solutions
5.9.4 Olainfarm JSC Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.9.5 Olainfarm JSC Recent Developments
5.10 Gilead Sciences, Inc.
5.10.1 Gilead Sciences, Inc. Profile
5.10.2 Gilead Sciences, Inc. Main Business
5.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Products, Services and Solutions
5.10.4 Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue (US$ Million) & (2015-2020)
5.10.5 Gilead Sciences, Inc. Recent Developments
6 North America
6.1 North America Pediatric Influenza Treatment Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Pediatric Influenza Treatment Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Influenza Treatment Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pediatric Influenza Treatment Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Influenza Treatment Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pediatric Influenza Treatment Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Pediatric Influenza Treatment Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Pediatric Influenza Treatment Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Pediatric Influenza Treatment Market Size by Region (2015-2020) (US$ Million)
Table 3. Global Pediatric Influenza Treatment Market Size Share by Region (2015-2020)
Table 4. Global Pediatric Influenza Treatment Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Pediatric Influenza Treatment Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Pediatric Influenza Treatment Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Pediatric Influenza Treatment Market Size by Type (2015-2020) (US$ Million)
Table 8. Global Pediatric Influenza Treatment Revenue Market Share by Type (2015-2020)
Table 9. Global Pediatric Influenza Treatment Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Pediatric Influenza Treatment Revenue Market Share by Type (2021-2026)
Table 11. Global Pediatric Influenza Treatment Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Pediatric Influenza Treatment Market Size by Application (2015-2020) (US$ Million)
Table 13. Global Pediatric Influenza Treatment Revenue Market Share by Application (2015-2020)
Table 14. Global Pediatric Influenza Treatment Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Pediatric Influenza Treatment Revenue Market Share by Application (2021-2026)
Table 16. Global Pediatric Influenza Treatment Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Pediatric Influenza Treatment Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Influenza Treatment as of 2019)
Table 19. Date of Key Manufacturers Enter into Pediatric Influenza Treatment Market
Table 20. Global Pediatric Influenza Treatment Top Players Headquarters and Area Served
Table 21. Pediatric Influenza Treatment Product Solution and Service
Table 22. Global Pediatric Influenza Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. F. Hoffmann-La Roche Ltd Basic Information List
Table 25. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 26. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Products, Services and Solutions
Table 27. Revenue (Million US$) in Pediatric Influenza Treatment Business of F. Hoffmann-La Roche Ltd (2015-2020)
Table 28. F. Hoffmann-La Roche Ltd Recent Developments
Table 29. GlaxoSmithKline Plc. Basic Information List
Table 30. GlaxoSmithKline Plc. Description and Business Overview
Table 31. GlaxoSmithKline Plc. Pediatric Influenza Treatment Products, Services and Solutions
Table 32. Revenue (Million US$) in Pediatric Influenza Treatment Business of GlaxoSmithKline Plc. (2015-2020)
Table 33. GlaxoSmithKline Plc. Recent Developments
Table 34. NATCO Pharma Limited. Basic Information List
Table 35. NATCO Pharma Limited. Description and Business Overview
Table 36. NATCO Pharma Limited. Pediatric Influenza Treatment Products, Services and Solutions
Table 37. Revenue (Million US$) in Pediatric Influenza Treatment Business of NATCO Pharma Limited. (2015-2020)
Table 38. NATCO Pharma Limited. Recent Developments
Table 39. NESHER PHARMS Basic Information List
Table 40. NESHER PHARMS Description and Business Overview
Table 41. NESHER PHARMS Pediatric Influenza Treatment Products, Services and Solutions
Table 42. Revenue (Million US$) in Pediatric Influenza Treatment Business of NESHER PHARMS (2015-2020)
Table 43. NESHER PHARMS Recent Developments
Table 44. Johnson & Johnsons Inc. Basic Information List
Table 45. Johnson & Johnsons Inc. Description and Business Overview
Table 46. Johnson & Johnsons Inc. Pediatric Influenza Treatment Products, Services and Solutions
Table 47. Revenue (Million US$) in Pediatric Influenza Treatment Business of Johnson & Johnsons Inc. (2015-2020)
Table 48. Johnson & Johnsons Inc. Recent Developments
Table 49. Cipla Basic Information List
Table 50. Cipla Description and Business Overview
Table 51. Cipla Pediatric Influenza Treatment Products, Services and Solutions
Table 52. Revenue (Million US$) in Pediatric Influenza Treatment Business of Cipla (2015-2020)
Table 53. Cipla Recent Developments
Table 54. Hetero Pharma Basic Information List
Table 55. Hetero Pharma Description and Business Overview
Table 56. Hetero Pharma Pediatric Influenza Treatment Products, Services and Solutions
Table 57. Revenue (Million US$) in Pediatric Influenza Treatment Business of Hetero Pharma (2015-2020)
Table 58. Hetero Pharma Recent Developments
Table 59. Teva Pharmaceutical pvt. Ltd. Basic Information List
Table 60. Teva Pharmaceutical pvt. Ltd. Description and Business Overview
Table 61. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Products, Services and Solutions
Table 62. Revenue (Million US$) in Pediatric Influenza Treatment Business of Teva Pharmaceutical pvt. Ltd. (2015-2020)
Table 63. Teva Pharmaceutical pvt. Ltd. Recent Developments
Table 64. Olainfarm JSC Basic Information List
Table 65. Olainfarm JSC Description and Business Overview
Table 66. Olainfarm JSC Pediatric Influenza Treatment Products, Services and Solutions
Table 67. Revenue (Million US$) in Pediatric Influenza Treatment Business of Olainfarm JSC (2015-2020)
Table 68. Olainfarm JSC Recent Developments
Table 69. Gilead Sciences, Inc. Basic Information List
Table 70. Gilead Sciences, Inc. Description and Business Overview
Table 71. Gilead Sciences, Inc. Pediatric Influenza Treatment Products, Services and Solutions
Table 72. Revenue (Million US$) in Pediatric Influenza Treatment Business of Gilead Sciences, Inc. (2015-2020)
Table 73. Gilead Sciences, Inc. Recent Developments
Table 74. North America Pediatric Influenza Treatment Market Size by Country (2015-2020) & (US$ Million)
Table 75. North America Pediatric Influenza Treatment Market Size Share by Country (2015-2020)
Table 76. Europe Pediatric Influenza Treatment Market Size by Country (2015-2020) & (US$ Million)
Table 77. Europe Pediatric Influenza Treatment Market Size Share by Country (2015-2020)
Table 78. Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2015-2020) & (US$ Million)
Table 79. Asia-Pacific Pediatric Influenza Treatment Market Size Share by Region (2015-2020) (US$ Million)
Table 80. Latin America Pediatric Influenza Treatment Market Size by Country (2015-2020) & (US$ Million)
Table 81. Latin America Pediatric Influenza Treatment Market Size Share by Country (2015-2020) (US$ Million)
Table 82. Middle East & Africa Pediatric Influenza Treatment Market Size by Players (2015-2020) (US$ Million)
Table 83. Middle East & Africa Pediatric Influenza Treatment Market Size Share by Players (2015-2020) (US$ Million)
Table 84. Pediatric Influenza Treatment Market Trends
Table 85. Pediatric Influenza Treatment Market Drivers
Table 86. Pediatric Influenza Treatment Market Challenges
Table 87. Pediatric Influenza Treatment Market Restriants
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Influenza Treatment Market Size Year-over-Year 2015-2026 & (US$ Million)
Figure 2. Global Pediatric Influenza Treatment Market Size (US$ Million), 2015 VS 2020VS 2026
Figure 3. Global Pediatric Influenza Treatment Market Share by Regions: 2020 VS 2026
Figure 4. North America Pediatric Influenza Treatment Market Size (US$ Million) Growth Rate (2015-2026)
Figure 5. Europe Pediatric Influenza Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Asia-Pacific Pediatric Influenza Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Pediatric Influenza Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Pediatric Influenza Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Pediatric Influenza Treatment Market Share by Type in 2020 & 2026
Figure 10. Antiviral Drug Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. Antipyretic Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. Neuraminidase inhibitor Market Size (US$ Million) YoY Growth (2015-2026)
Figure 13. Others Market Size (US$ Million) YoY Growth (2015-2026)
Figure 14. Global Pediatric Influenza Treatment Market Size Share by Application in 2020 & 2026
Figure 15. Hospitals Market Size (US$ Million) YoY Growth (2015-2026)
Figure 16. Clinics Market Size (US$ Million) YoY Growth (2015-2026)
Figure 17. Ambulatory Surgical Centers Market Size (US$ Million) YoY Growth (2015-2026)
Figure 18. Others Market Size (US$ Million) YoY Growth (2015-2026)
Figure 19. Pediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Top 5 and Top 10 Players Pediatric Influenza Treatment Market Share in 2019
Figure 21. United States Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Canada Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Rest of Europe Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Rest of Latin America Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Pediatric Influenza Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Keyplayers in Global Pediatric Influenza Treatment Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
F. Hoffmann-La Roche LtdGlaxoSmithKline Plc.
NATCO Pharma Limited.
NESHER PHARMS
Johnson & Johnsons Inc.
Cipla
Hetero Pharma
Teva Pharmaceutical pvt. Ltd.
Olainfarm JSC
Gilead Sciences, Inc.